DiaMedica Therapeutics, Inc. (DMAC)
6.43
+0.11
(+1.74%)
USD |
NASDAQ |
May 11, 13:51
DiaMedica Therapeutics Shareholders Equity (Quarterly) : 47.24M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| IN8bio, Inc. | 22.78M |
| Calidi Biotherapeutics, Inc. | 3.759M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 53.08M |
| Total Liabilities (Quarterly) | 5.845M |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 9.110 |
| Net Debt Paydown Yield | 0.01% |